Table 1.
Podlekareva et al. 2013 [13]
|
Survey (reported)
|
Baseline (actual)
|
|||
---|---|---|---|---|---|
Criteria | Score | Criteria | Score | Criteria | Score |
Performance of DST for M. tuberculosis | 1 | DST routinely performed | 1 | Had a resistance result at baseline (within 1 month of the TB diagnosis date) | 1 |
Inclusion of rifamycin (R), isoniazid (H) and pyrazinamide (Z) in the initial anti-tuberculosis treatment regimen | 2 | Standard initial anti-TB treatment for HIV/TB-coinfected patients contains RHZE | 2 | Initial treatment (drugs started on the first date of starting treatment) contained at least RHZE | 2 |
Initiation of cART (a combination of at least three antiretroviral drugs from any class) before or up to 1 month after TB diagnosis | 2 | Start as soon as possible and within 2 months after TB diagnosis irrespective of CD4 count | 2 | cART (3 or more antiretroviral drugs from any class) was initiated before or up to 2 months after the TB diagnosis date | 2 |
CI: DST, drug susceptibility testing; cART, combination antiretroviral therapy; TB, tuberculosis.